Canada Passes Law Authorizing Generic Drug Exports

Law360, New York (May 16, 2004, 12:00 AM EDT) -- The Canadian Senate has passed a bill that will allow generic drug manufacturers in Canada to produce copies of patented treatments for HIV, AIDS, tuberculosis and malaria and export them to resource-limited countries.

The Jean Chretien Pledge to Africa Act, named after Canada’s outgoing prime minister, was drafted last year following a challenge to his home country by United Nations Special Envoy Stephen Lewis.

Lewis called on Canada to take the lead in lowering the cost of medications after nations reached agreement at the World Trade...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.